GlassScriptPhysician profile
Amanda N Strudthoff
NPI 1275027823
$8,415.37
in general payments reported to CMS, 2019-2025
32 companies · $2,486 in 2025
The $2,486 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.21 · 2022: $2,282 · 2023: $2,132 · 2024: $1,502 · 2025: $2,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,450 · Education: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,449.88 |
| Education | $670.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,025.34 | 2022-2025 | Tremfya, Simponi, Simponi Aria |
| Abbvie INC. | $975.62 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $830.19 | 2022-2025 | Winlevi, Absorica Ld, Ilumya |
| Regeneron Healthcare Solutions, INC. | $704.94 | 2022-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $701.16 | 2022-2025 | |
| Genzyme Corporation | $649.78 | 2022-2025 | |
| Lilly USA, LLC | $616.34 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $398.80 | 2022-2024 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $341.90 | 2023-2025 | Sotyktu |
| Ucb, INC. | $308.06 | 2022-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $263.57 | 2022-2025 | |
| Amgen INC. | $229.25 | 2022-2025 | Otezla, Enbrel, Otezla |
| Leo Pharma INC. | $194.32 | 2022-2025 | Anzupgo, Adbry |
| Convatec INC. | $189.17 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $140.06 | 2022-2024 | Jublia, Arazlo, Cabtreo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $126.95 | 2022 | |
| Almirall LLC | $126.29 | 2022-2024 | Seysara |
| Galderma Laboratories, L.P. | $95.15 | 2022-2025 | Nemluvio |
| Dermavant Sciences, INC. | $72.94 | 2023-2024 | Vtama |
| Sanofi-Aventis U.S. LLC | $64.99 | 2022 | |
| Nabriva Therapeutics, Plc | $51.25 | 2022 | |
| Organon LLC | $47.33 | 2025 | Vtama |
| Arcutis Biotherapeutics, INC. | $40.23 | 2023 | |
| Biofrontera INC. | $39.60 | 2023-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Mayne Pharma Commercial LLC | $37.78 | 2022-2025 | |
| Organogenesis INC. | $33.42 | 2025 | Via Matrix |
| Blueprint Medicines Corporation | $22.07 | 2023 | |
| Paratek Pharmaceuticals, INC. | $22.02 | 2024 | Nuzyra |
| Verrica Pharmaceuticals INC. | $21.28 | 2023 | Ycanth |
| Lnhc, INC | $18.33 | 2025 | Zelsuvmi |
| Kyowa Kirin, INC. | $14.03 | 2022 | |
| Stryker Corporation | $13.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Strudthoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.